{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:03:46Z","timestamp":1789985026116,"version":"4.0.1"},"reference-count":190,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:00:00Z","timestamp":1789862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Faculty of Medicine, University of Belgrade","award":["451-03-34\/2026-03\/200110"],"award-info":[{"award-number":["451-03-34\/2026-03\/200110"]}]},{"award":["451-03-34\/2026-03\/200110"],"award-info":[{"award-number":["451-03-34\/2026-03\/200110"]}],"id":[{"id":"https:\/\/ror.org\/02qsmb048","id-type":"ROR","asserted-by":"publisher"}]},{"name":"University of Belgrade\u2014Faculty of Pharmacy","award":["451-03-33\/2026-03\/200161"],"award-info":[{"award-number":["451-03-33\/2026-03\/200161"]}]},{"name":"University of Belgrade\u2014Faculty of Pharmacy","award":["451-03-34\/2026-03\/200161"],"award-info":[{"award-number":["451-03-34\/2026-03\/200161"]}]},{"award":["451-03-33\/2026-03\/200161"],"award-info":[{"award-number":["451-03-33\/2026-03\/200161"]}],"id":[{"id":"https:\/\/ror.org\/02qsmb048","id-type":"ROR","asserted-by":"publisher"}]},{"award":["451-03-34\/2026-03\/200161"],"award-info":[{"award-number":["451-03-34\/2026-03\/200161"]}],"id":[{"id":"https:\/\/ror.org\/02qsmb048","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide and a leading cause of advanced liver fibrosis, cirrhosis, and hepatocellular carcinoma. The disease develops through the interaction of multiple interconnected pathophysiological mechanisms, including insulin resistance, dysregulated lipid metabolism, oxidative stress, mitochondrial and endoplasmic reticulum dysfunction, chronic inflammation, gut\u2013liver axis disruption, and progressive fibrogenesis. Betaine, a naturally occurring methyl donor, has been investigated as a potential therapeutic agent because of its diverse metabolic and cytoprotective effects. This review summarizes current knowledge on the mechanisms by which betaine may influence MASLD development and progression. Preclinical studies indicate that betaine improves insulin sensitivity and hepatic lipid homeostasis, reduces oxidative and endoplasmic reticulum stress, preserves mitochondrial function, mitigates inflammatory signaling, and limits hepatic fibrosis. In addition, growing evidence suggests that betaine contributes to the maintenance of gut\u2013liver axis homeostasis, further supporting its beneficial effects on liver function. Although these findings are consistent across preclinical models, clinical evidence remains limited, and the therapeutic efficacy of betaine in patients with MASLD has not yet been established. Further well-designed clinical trials are required to determine its clinical value, optimal therapeutic strategy, and potential role in the management of MASLD.<\/jats:p>","DOI":"10.3390\/antiox15091209","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:03:47Z","timestamp":1789977827000},"page":"1209","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Betaine in Metabolic Dysfunction-Associated Steatotic Liver Disease: Mechanisms of Action and Therapeutic Potential"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1701-3313","authenticated-orcid":false,"given":"Tatjana","family":"Radosavljevic","sequence":"first","affiliation":[{"name":"Institute of Pathophysiology \u201cLjubodrag Buba Mihailovic\u201d, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8457-4962","authenticated-orcid":false,"given":"Jasmina","family":"Djuretic","sequence":"additional","affiliation":[{"name":"Department of Pathobiology, Faculty of Pharmacy, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milica","family":"Brankovic","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8464-4924","authenticated-orcid":false,"given":"Janko","family":"Samardzic","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7009-3933","authenticated-orcid":false,"given":"Ivana","family":"Curuvija","sequence":"additional","affiliation":[{"name":"Institute of Virology, Vaccines and Sera \u201cTorlak\u201d, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danijela","family":"Vucevic","sequence":"additional","affiliation":[{"name":"Institute of Pathophysiology \u201cLjubodrag Buba Mihailovic\u201d, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra2412865","article-title":"Metabolic dysfunction-associated steatotic liver disease","volume":"393","author":"Targher","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jama.2025.19615","article-title":"Metabolic dysfunction-associated steatotic liver disease in adults: A review","volume":"335","author":"Tilg","year":"2026","journal-title":"JAMA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"101557","DOI":"10.1016\/j.lanepe.2025.101557","article-title":"Real-world evidence in metabolic dysfunction-associated steatotic liver disease (MASLD): Insights, challenges, and future directions","volume":"62","author":"Huang","year":"2025","journal-title":"Lancet Reg. Health Eur."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Olaez-Ramos, C.E., Mojica-Zamudio, K.L., Sandoval-Rodr\u00edguez, A., and Armend\u00e1riz-Borunda, J. (2026). Epidemiology and diagnostic of MASLD in Latin America: A yet to be met challenge. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1700072"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S2213-8587(24)00318-8","article-title":"Metabolic dysfunction-associated steatotic liver disease: Heterogeneous pathomechanisms and effectiveness of metabolism-based treatment","volume":"13","author":"Stefan","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/dom.70659","article-title":"Obesity and metabolic dysfunction-associated steatotic liver disease (MASLD): A literature review on pathophysiology and treatment","volume":"28","author":"Romanos","year":"2026","journal-title":"Diabetes Obes. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Kim, B.K. (2026). Metabolic dysfunction-associated steatotic liver disease and obesity: Pathogenesis, diagnostics, risk stratification, and therapeutic approach. Kaohsiung J. Med. Sci., e70227.","DOI":"10.1002\/kjm2.70227"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3892\/ijmm.2025.5587","article-title":"Protective effect of exercise on metabolic dysfunction-associated fatty liver disease: Potential epigenetic mechanisms (Review)","volume":"56","author":"Zhang","year":"2025","journal-title":"Int. J. Mol. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"101182","DOI":"10.1016\/j.aohep.2023.101182","article-title":"Insulin resistance and metabolic dysfunction-associated steatotic liver disease (MASLD): Pathways of action of hypoglycemic agents","volume":"29","author":"Uribe","year":"2024","journal-title":"Ann. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Syed-Abdul, M.M. (2023). Lipid metabolism in metabolic-associated steatotic liver disease (MASLD). Metabolites, 14.","DOI":"10.3390\/metabo14010012"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"101185","DOI":"10.1016\/j.jhepr.2024.101185","article-title":"Lipid metabolism in MASLD and MASH: From mechanism to the clinic","volume":"6","author":"Carli","year":"2024","journal-title":"JHEP Rep."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Jin, J., and Cheng, Y. (2026). Mitochondrial dysfunction in metabolic-syndrome-related MASLD\/MASH: Metabolic mechanisms and therapeutic perspectives. Metabolites, 16.","DOI":"10.3390\/metabo16070489"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Radosavljevic, T., Brankovic, M., Samardzic, J., Djureti\u0107, J., Vukicevic, D., Vucevic, D., and Jakovljevic, V. (2024). Altered mitochondrial function in MASLD: Key features and promising therapeutic approaches. Antioxidants, 13.","DOI":"10.3390\/antiox13080906"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"101777","DOI":"10.1016\/j.aohep.2025.101777","article-title":"From gut to liver: Exploring the crosstalk between the gut\u2013liver axis and oxidative stress in metabolic dysfunction-associated steatotic liver disease","volume":"30","author":"Zhou","year":"2025","journal-title":"Ann. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Zhao, G., He, F., Wu, C., Li, P., Li, N., Deng, J., Zhu, G., Ren, W., and Peng, Y. (2018). Betaine in inflammation: Mechanistic aspects and applications. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.01070"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"116069","DOI":"10.1016\/j.biopha.2023.116069","article-title":"Roles of immune dysregulation in MASLD","volume":"170","author":"Dong","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Capuccio, S., Cocuzza, C., Di Marco, G.L., Scamporrino, A., Piro, S., and Russello, M. (2026). Metabolic dysfunction-associated steatotic liver disease (MASLD): From steatosis to systemic metabolic failure: Classical pathophysiology, emerging systemic mechanisms and modifiable lifestyle determinants. Nutrients, 18.","DOI":"10.3390\/nu18142316"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jhep.2025.02.033","article-title":"Integrative metabolism in MASLD and MASH: Pathophysiology and emerging mechanisms","volume":"83","author":"Steinberg","year":"2025","journal-title":"J. Hepatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41572-025-00599-1","article-title":"Metabolic dysfunction-associated steatotic liver disease in adults","volume":"11","author":"Huang","year":"2025","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_22","first-page":"313","article-title":"Pathophysiology of metabolic dysfunction associated steatotic liver disease","volume":"1","year":"2025","journal-title":"Cl\u00edn. Gastroenterol. M\u00e9x."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e70132","DOI":"10.1002\/edm2.70132","article-title":"Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Mechanisms, Clinical Implications and Therapeutic Advances","volume":"8","author":"Miller","year":"2025","journal-title":"Endocrinol. Diabetes Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s44355-025-00030-2","article-title":"Pathophysiology, noninvasive diagnostics and emerging personalized treatments for metabolic associated liver diseases","volume":"2","author":"Tantu","year":"2025","journal-title":"npj Gut Liver"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Younossi, Z.M., Kalligeros, M., Wong, V.W., Al-Naamani, K.M., Tacke, F., Tsochatzis, E., Crespo, J., El-Kassas, M., Bril, F., and Arrese, M. (Clin. Gastroenterol. Hepatol., 2026). Updated global consensus recommendations for risk stratification, treatment initiation, and response monitoring in metabolic dysfunction-associated steatotic liver disease, Clin. Gastroenterol. Hepatol., in press.","DOI":"10.3350\/cmh.2024.0431"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1053\/j.gastro.2025.02.044","article-title":"Global consensus recommendations for metabolic dysfunction-associated steatotic liver disease and steatohepatitis","volume":"169","author":"Younossi","year":"2025","journal-title":"Gastroenterology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1053\/j.gastro.2025.04.061","article-title":"Global MASLD consensus: Inclusive in scope, exclusive in therapy?","volume":"170","author":"Kumar","year":"2026","journal-title":"Gastroenterology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1053\/j.gastro.2025.09.047","article-title":"Re-evaluating lifestyle interventions in normal weight metabolic dysfunction-associated steatotic liver disease","volume":"170","author":"Bhadoria","year":"2026","journal-title":"Gastroenterology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/flgastro-2025-103183","article-title":"Nutrition in MASLD: A patient-focused, evidence-based clinician\u2019s guide","volume":"17","author":"Pekarska","year":"2026","journal-title":"Frontline Gastroenterol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Arumugam, M.K., Paal, M.C., Donohue, T.M., Ganesan, M., Osna, N.A., and Kharbanda, K.K. (2021). Beneficial effects of betaine: A comprehensive review. Biology, 10.","DOI":"10.3390\/biology10060456"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Buonaiuto, G., Federiconi, A., Vecchiato, C.G., Benini, E., and Mordenti, A.L. (2025). Betaine dietary supplementation: Healthy aspects in human and animal nutrition. Antioxidants, 14.","DOI":"10.3390\/antiox14070771"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"104993","DOI":"10.1016\/j.tifs.2025.104993","article-title":"Betaine: A comprehensive review on dietary sources, health benefits, mechanisms of action, and application","volume":"159","author":"Yang","year":"2025","journal-title":"Trends Food Sci. Technol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Singh, S.K., Yadav, P., Bishnolia, M., Manhar, N., Kumar, P., Navik, U., and Weiskirchen, R. (2026). Betaine as a regulator of metabolism, epigenetics, and cellular osmoprotection: Therapeutic implications in cardiometabolic and renal diseases. Front. Pharmacol., 17.","DOI":"10.3389\/fphar.2026.1883688"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/ajcn\/80.3.539","article-title":"Betaine in human nutrition","volume":"80","author":"Craig","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1079\/NRR200493","article-title":"Potential nutritional and physiological functions of betaine in livestock","volume":"18","author":"Eklund","year":"2005","journal-title":"Nutr. Res. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e70173","DOI":"10.1002\/fsn3.70173","article-title":"Recent Advances in Betaine: Extraction, Identification, and Bioactive Functions in Human Health","volume":"13","author":"Luo","year":"2025","journal-title":"Food Sci. Nutr."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.bbagen.2016.02.001","article-title":"Betaine chemistry, roles, and potential use in liver disease","volume":"1860","author":"Day","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Dobrijevi\u0107, D., Pastor, K., Nasti\u0107, N., Ozogul, F., Krulj, J., Koki\u0107, B., Bartkiene, E., Rocha, J.M., and Koji\u0107, J. (2023). Betaine as a functional ingredient: Metabolism, health-promoting attributes, food sources, applications and analysis methods. Molecules, 28.","DOI":"10.3390\/molecules28124824"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10545-010-9088-4","article-title":"Choline and betaine in health and disease","volume":"34","author":"Ueland","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1550-2783-6-7","article-title":"Effect of betaine supplementation on power performance and fatigue","volume":"6","author":"Hoffman","year":"2009","journal-title":"J. Int. Soc. Sports Nutr."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.clinbiochem.2010.03.009","article-title":"The clinical significance of betaine, an osmolyte with a key role in methyl group metabolism","volume":"43","author":"Lever","year":"2010","journal-title":"Clin. Biochem."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Liu, Y., Li, Q., Liu, R., Wang, Z., and Zhao, S. (2026). Exploring the multifunctional roles of betaine: Traditional applications, emerging technologies, and green chemistry innovations. Foods, 15.","DOI":"10.3390\/foods15040737"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1016\/j.cell.2025.06.001","article-title":"Systematic profiling reveals betaine as an exercise mimetic for geroprotection","volume":"188","author":"Geng","year":"2025","journal-title":"Cell"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Xu, Y., Gao, J., Wang, M., and Zhang, H. (2026). Exercise-mimicking effects of betaine in chronic disease prevention and management. Front. Nutr., 12.","DOI":"10.3389\/fnut.2025.1762908"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Liu, Y., and Lin, J. (2025). Betaine: A promising novel anti-aging substance as an exercise mimetic. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1672934"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"DiGiacomo, K., Simpson, S., Leury, B.J., and Dunshea, F.R. (2023). Dietary Betaine Impacts Metabolic Responses to Moderate Heat Exposure in Sheep. Animals, 13.","DOI":"10.3390\/ani13101691"},{"key":"ref_47","first-page":"30","article-title":"Glycine betaine as an osmolyte for plant protection against abiotic stress: A comprehensive review","volume":"6","author":"Alharazi","year":"2025","journal-title":"J. Chem. Nutr. Biochem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/jpn.12990","article-title":"Osmoregulatory function of betaine in alleviating heat stress in poultry","volume":"102","author":"Ratriyanto","year":"2018","journal-title":"J. Anim. Physiol. Anim. Nutr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.5713\/ajas.2009.80659","article-title":"Metabolic, osmoregulatory and nutritional functions of betaine in monogastric animals","volume":"22","author":"Ratriyanto","year":"2009","journal-title":"Asian-Australas. J. Anim. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Willingham, B.D., Ragland, T.J., and Ormsbee, M.J. (2020). Betaine supplementation may improve heat tolerance: Potential mechanisms in humans. Nutrients, 12.","DOI":"10.3390\/nu12102939"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Wang, H., Li, S., Fang, S., Yang, X., and Feng, J. (2018). Betaine improves intestinal functions by enhancing digestive enzymes, ameliorating intestinal morphology, and enriching intestinal microbiota in high-salt stressed rats. Nutrients, 10.","DOI":"10.3390\/nu10070907"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1472-765X.2005.01757.x","article-title":"Accumulation of the compatible solutes glycine betaine and ectoine in osmotic stress adaptation and heat shock cross-protection in the biocontrol agent Pantoea agglomerans CPA-2","volume":"41","author":"Usall","year":"2005","journal-title":"Lett. Appl. Microbiol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"De Angelis, E., Borghetti, P., Passeri, B., Cavalli, V., Ferrari, L., Andrani, M., Martelli, P., and Saleri, R. (2024). Hyperosmotic stress induces the expression of organic osmolyte transporters in porcine intestinal cells and betaine exerts a protective effect on the barrier function. Biomedicines, 12.","DOI":"10.3390\/biomedicines12102391"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1152\/ajpcell.00327.2011","article-title":"Tonicity-independent regulation of the osmosensitive transcription factor TonEBP (NFAT5)","volume":"302","author":"Halterman","year":"2012","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1038\/s41467-019-11302-w","article-title":"TonEBP\/NFAT5 promotes obesity and insulin resistance by epigenetic suppression of white adipose tissue beiging","volume":"10","author":"Lee","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/s41581-020-0261-1","article-title":"The evolving role of TonEBP as an immunometabolic stress protein","volume":"16","author":"Choi","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Eronina, T.B., Mikhaylova, V.V., Chebotareva, N.A., Tugaeva, K.V., and Kurganov, B.I. (2022). Effect of betaine and arginine on interaction of \u03b1B-crystallin with glycogen phosphorylase b. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23073816"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ijbiomac.2022.01.106","article-title":"Combined action of chemical chaperones on stability, aggregation and oligomeric state of muscle glycogen phosphorylase b","volume":"203","author":"Eronina","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Bortz, J., and Obeid, R. (2025). The shuttling of methyl groups between folate and choline pathways. Nutrients, 17.","DOI":"10.3390\/nu17152495"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"108114","DOI":"10.1016\/j.phrs.2026.108114","article-title":"The SAM-m6A axis as an unexplored therapeutic hub for plant-derived regulation of disease metabolism","volume":"225","author":"Zhao","year":"2026","journal-title":"Pharmacol. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"117726","DOI":"10.1016\/j.cca.2023.117726","article-title":"SAH and SAM\/SAH ratio associate with acute kidney injury in critically ill patients: A case-control study","volume":"553","author":"Liu","year":"2024","journal-title":"Clin. Chim. Acta"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1093\/jn\/131.11.2811","article-title":"Intracellular S-Adenosylhomocysteine Concentrations Predict Global DNA Hypomethylation in Tissues of Methyl-Deficient Cystathionine Beta-Synthase Heterozygous Mice","volume":"131","author":"Caudill","year":"2001","journal-title":"J. Nutr."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"7298","DOI":"10.1038\/s41598-025-91573-0","article-title":"Profiling of RNA N6-methyladenosine methylation reveals the critical role of m6A in betaine alleviating hepatic steatosis","volume":"15","author":"Wu","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Zhu, Q., Hu, Y., Li, M., Yang, H., Zhao, L., and Zhao, Y. (2026). N6-Methyladenosine (m6A)-Mediated Regulation of Lipid Metabolism: Molecular Mechanisms, Pathological Implications, and Therapeutic Perspectives. Biomolecules, 16.","DOI":"10.3390\/biom16010101"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"103026","DOI":"10.1016\/j.redox.2024.103026","article-title":"Betaine alleviates cognitive impairment induced by homocysteine through attenuating NLRP3-mediated microglial pyroptosis in an m6A-YTHDF2-dependent manner","volume":"69","author":"Yang","year":"2024","journal-title":"Redox Biol."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Djureti\u0107, J., Filipovic, J., Brankovic, M., Stankovic, S., Samardzic, J., Vucevic, D., and Radosavljevic, T. (2025). Macrophage inhibitory factor in myocardial oxidative stress and inflammation during thioacetamide-induced liver fibrosis: Modulation by betaine. Curr. Issues Mol. Biol., 47.","DOI":"10.3390\/cimb47090728"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1017\/S0007114522002975","article-title":"Dietary betaine intake and risk of mortality in patients with coronary artery disease: The prospective Guangdong coronary artery disease cohort","volume":"130","author":"Liu","year":"2023","journal-title":"Br. J. Nutr."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"6516","DOI":"10.1080\/10408398.2021.1902938","article-title":"Effects of betaine supplementation on cardiovascular markers: A systematic review and meta-analysis","volume":"62","author":"Bagheri","year":"2022","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Radosavljevic, T., Vukicevic, D., Djureti\u0107, J., Gopcevic, K., Labudovic Borovic, M., Stankovic, S., Samardzic, J., Radosavljevic, M., Vucevic, D., and Jakovljevic, V. (2024). The role of macrophage inhibitory factor in TAA-induced liver fibrosis in mice: Modulatory effects of betaine. Biomedicines, 12.","DOI":"10.3390\/biomedicines12061337"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.2174\/0929867327666201104151025","article-title":"The role of MIF in hepatic function, oxidative stress, and inflammation in thioacetamide-induced liver injury in mice: Protective effects of betaine","volume":"28","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1017\/S1431927620024265","article-title":"Effect of betaine supplementation on liver tissue and ultrastructural changes in methionine-choline-deficient diet-induced NAFLD","volume":"26","year":"2020","journal-title":"Microsc. Microanal."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejphar.2019.01.043","article-title":"Betaine modulates oxidative stress, inflammation, apoptosis, autophagy, and Akt\/mTOR signaling in methionine-choline deficiency-induced fatty liver disease","volume":"848","author":"Borozan","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1017\/S1431927617012806","article-title":"The effects of betaine on the nuclear fractal dimension, chromatin texture, and proliferative activity in hepatocytes in a mouse model of nonalcoholic fatty liver disease","volume":"24","author":"Zaletel","year":"2018","journal-title":"Microsc. Microanal."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"5254","DOI":"10.2174\/0929867329666220408102856","article-title":"Betaine modulating MIF-mediated oxidative stress, inflammation and fibrogenesis in thioacetamide-induced nephrotoxicity","volume":"29","year":"2022","journal-title":"Curr. Med. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"105496","DOI":"10.1016\/j.psj.2025.105496","article-title":"Betaine decreases hepatic lipid deposition through DNA 5mC and RNA m6A methylation-mediated regulation of fatty acid metabolic gene expression in laying hens","volume":"104","author":"Yang","year":"2025","journal-title":"Poult. Sci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"109738","DOI":"10.1016\/j.jnutbio.2024.109738","article-title":"Betaine alleviates nonalcoholic fatty liver disease (NAFLD) via a mechanism involving BHMT\/FTO\/m6A\/PGC1\u03b1 signaling","volume":"134","author":"Liu","year":"2024","journal-title":"J. Nutr. Biochem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1053\/j.jrn.2024.03.009","article-title":"Plasma concentrations of trimethylamine-N-oxide, choline, and betaine in patients with moderate to advanced chronic kidney disease and their relation to cardiovascular and renal outcomes","volume":"34","author":"Obeid","year":"2024","journal-title":"J. Ren. Nutr."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"110076","DOI":"10.1016\/j.abb.2024.110076","article-title":"Betaine ameliorates arsenic-induced kidney injury in mice by mitigating oxidative stress-mediated inflammation","volume":"758","author":"Norouzzadeh","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1089\/met.2023.0096","article-title":"Dietary intakes of choline and betaine and incidence of type 2 diabetes: Tehran Lipid and Glucose Study","volume":"21","author":"Koochakpoor","year":"2023","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s10989-019-09922-3","article-title":"Betaine: A promising micronutrient in diet intervention for ameliorating maternal blood biochemical alterations in gestational diabetes mellitus","volume":"26","author":"Salahi","year":"2020","journal-title":"Int. J. Pept. Res. Ther."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1017\/S0954422421000056","article-title":"Effects of betaine on non-alcoholic liver disease","volume":"35","author":"Chen","year":"2022","journal-title":"Nutr. Res. Rev."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"174604","DOI":"10.1016\/j.ejphar.2021.174604","article-title":"Preventive and therapeutic role of betaine in liver disease: A review on molecular mechanisms","volume":"912","author":"Wang","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s43856-026-01651-1","article-title":"The role of hepatocyte epigenetics in the pathogenesis of metabolic dysfunction-associated steatotic liver disease","volume":"6","author":"Zhu","year":"2026","journal-title":"Commun. Med."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Kathirvel, E., Morgan, K., Malysheva, O.V., Caudill, M.A., and Morgan, T.R. (2024). Betaine for the prevention and treatment of insulin resistance and fatty liver in a high-fat dietary model of insulin resistance in C57BL mice. Front. Nutr., 11.","DOI":"10.3389\/fnut.2024.1409972"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.tjnut.2024.02.025","article-title":"Dietary betaine improves glucose metabolism in obese mice","volume":"154","author":"Xu","year":"2024","journal-title":"J. Nutr."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s00394-020-02362-6","article-title":"Betaine prevented high-fat diet-induced NAFLD by regulating the FGF10\/AMPK signaling pathway in ApoE\u2212\/\u2212 mice","volume":"60","author":"Chen","year":"2021","journal-title":"Eur. J. Nutr."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejphar.2015.11.043","article-title":"Betaine prevented fructose-induced NAFLD by regulating the LXR\u03b1\/PPAR\u03b1 pathway and alleviating endoplasmic reticulum stress in rats","volume":"770","author":"Ge","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Li, Y., Jiang, W., Feng, Y., Wu, L., Jia, Y., and Zhao, R. (2022). Betaine alleviates high-fat diet-induced disruption of hepatic lipid and iron homeostasis in mice. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23116263"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e71315","DOI":"10.1096\/fj.202501416RRRR","article-title":"Betaine attenuates high-fat-diet-induced metabolism-associated steatotic liver disease via the inhibition of ferroptosis through the Nrf2\/GPX4 axis","volume":"39","author":"Zhai","year":"2025","journal-title":"FASEB J."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e70657","DOI":"10.1111\/cns.70657","article-title":"AMPK\/SIRT1\/PGC-1\u03b1 signaling pathway: Molecular mechanisms and targeted strategies from energy homeostasis regulation to disease therapy","volume":"31","author":"Chen","year":"2025","journal-title":"CNS Neurosci. Ther."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.bbrc.2016.06.080","article-title":"Alleviation of hepatic fat accumulation by betaine involves reduction of homocysteine via up-regulation of betaine-homocysteine methyltransferase (BHMT)","volume":"477","author":"Ahn","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e70062","DOI":"10.1002\/jsp2.70062","article-title":"Phosphatidylcholine ameliorates palmitic acid-induced lipotoxicity by facilitating endoplasmic reticulum and mitochondria contacts in intervertebral disc degeneration","volume":"8","author":"Dong","year":"2025","journal-title":"JOR Spine"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1017\/S0007114512000888","article-title":"Betaine reduces the expression of inflammatory adipokines caused by hypoxia in human adipocytes","volume":"143","author":"Olli","year":"2013","journal-title":"J. Nutr."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"107060","DOI":"10.1016\/j.jff.2025.107060","article-title":"Oral betaine ameliorates high-fat diet-induced hepatic steatosis in mice by inducing miR-96-5p targeting IGF1R","volume":"134","author":"Xie","year":"2025","journal-title":"J. Funct. Foods"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.cmet.2024.04.006","article-title":"Hepatic selective insulin resistance at the intersection of insulin signaling and MASLD","volume":"36","author":"Rui","year":"2024","journal-title":"Cell Metab."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/s42255-025-01349-z","article-title":"The insulin signalling network","volume":"7","author":"Burchfield","year":"2025","journal-title":"Nat. Metab."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41575-026-01202-y","article-title":"Deciphering cytochrome P450 reductase role in MASLD: Molecular mechanisms and pathophysiological implications","volume":"23","author":"Baptista","year":"2026","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41387-018-0035-z","article-title":"Maternal betaine supplementation affects fetal growth and lipid metabolism of high-fat-fed mice in a temporal-specific manner","volume":"8","author":"Joselit","year":"2018","journal-title":"Nutr. Diabetes"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.tjnut.2024.10.036","article-title":"Betaine and B12 intake, glutathione concentration, and MTHFR, PEMT, and MTHFD1 genotypes are associated with diabetes-related parameters in Polish adults","volume":"155","author":"Szwengiel","year":"2025","journal-title":"J. Nutr."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1042\/EBC20240007","article-title":"New developments in AMPK and mTORC1 cross-talk","volume":"68","author":"Smiles","year":"2024","journal-title":"Essays Biochem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"122","DOI":"10.17480\/psk.2026.70.2.122","article-title":"Betaine regulates hepatic inflammation in obese mice: FOXO6 activation","volume":"70","author":"Hwang","year":"2026","journal-title":"Yakhak Hoeji"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1089\/jmf.2024.k.0150","article-title":"Betaine suppresses lipid accumulation in liver: Inhibition of FoxO6 and PPAR\u03b3 interaction","volume":"27","author":"Park","year":"2024","journal-title":"J. Med. Food"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1476-511X-12-34","article-title":"Betaine supplement alleviates hepatic triglyceride accumulation of apolipoprotein E-deficient mice via reducing methylation of peroxisome proliferator-activated receptor alpha promoter","volume":"12","author":"Wang","year":"2013","journal-title":"Lipids Health Dis."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Zhou, J., Zhu, B., Bing, Z., Wang, T., and Zhao, Y. (2026). The gut\u2013liver axis in MASLD: From host\u2013microbiome crosstalk to precision therapeutics. Microorganisms, 14.","DOI":"10.3390\/microorganisms14020471"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Perumal, S.K., Arumugam, M.K., Osna, N.A., Rasineni, K., and Kharbanda, K.K. (2025). Betaine regulates the gut\u2013liver axis: A therapeutic approach for chronic liver diseases. Front. Nutr., 12.","DOI":"10.3389\/fnut.2025.1478542"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"41606","DOI":"10.1038\/srep41606","article-title":"AMPK regulates lipid accumulation in skeletal muscle cells through FTO-dependent demethylation of N6-methyladenosine","volume":"7","author":"Wu","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11901-026-00743-9","article-title":"Epitranscriptomic remodeling: M6A methylation as a master regulator of de novo lipogenesis in MASLD","volume":"25","author":"Barbhuiya","year":"2026","journal-title":"Curr. Hepatol. Rep."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Deng, Y., Dong, Y., Zhang, S., and Feng, Y. (2024). Targeting mitochondrial homeostasis in the treatment of non-alcoholic fatty liver disease: A review. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1463187"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Mej\u00eda-Guzm\u00e1n, J.E., Belmont-Hern\u00e1ndez, R.A., Ch\u00e1vez-Tapia, N.C., Uribe, M., and Nu\u00f1o-L\u00e1mbarri, N. (2025). Metabolic-dysfunction-associated steatotic liver disease: Molecular mechanisms, clinical implications, and emerging therapeutic strategies. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26072959"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"7981","DOI":"10.1021\/acs.jafc.2c02940","article-title":"miR-143-mediated responses to betaine supplement repress lipogenesis and hepatic gluconeogenesis by targeting MAT1A and MAPK11","volume":"70","author":"Chen","year":"2022","journal-title":"J. Agric. Food Chem."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00726-014-1913-x","article-title":"Betaine supplementation prevents fatty liver induced by a high-fat diet: Effects on one-carbon metabolism","volume":"47","author":"Deminice","year":"2015","journal-title":"Amino Acids"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Preedy, V.R. (2015). Betaine, DNA methylation and nonalcoholic fatty liver disease. Betaine: Chemistry, Analysis, Function and Effects, Royal Society of Chemistry.","DOI":"10.1039\/9781782628446"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"8886237","DOI":"10.1155\/2024\/8886237","article-title":"Betaine alleviates high-fat diet-induced excessive lipid deposition in gibel carp hepatopancreas and L8824 cells by enhancing VLDL secretion through the HNF4\u03b1\/MTTP pathway","volume":"2024","author":"Dong","year":"2024","journal-title":"Aquac. Nutr."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2141\/jpsa.0200003","article-title":"Betaine alleviates heat stress-induced hepatic and mitochondrial oxidative damage in broilers","volume":"58","author":"Wen","year":"2021","journal-title":"J. Poult. Sci."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"4596572","DOI":"10.1155\/anu\/4596572","article-title":"Dietary betaine improves immune function, antioxidant status, immune-related signaling molecules, and disease resistance in fish species","volume":"2025","author":"Yousefi","year":"2025","journal-title":"Aquac. Nutr."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"G1068","DOI":"10.1152\/ajpgi.00249.2010","article-title":"Betaine improves nonalcoholic fatty liver and associated hepatic insulin resistance: A potential mechanism for hepatoprotection by betaine","volume":"299","author":"Kathirvel","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"112946","DOI":"10.1016\/j.biopha.2022.112946","article-title":"The anti-diabetic potential of betaine: Mechanisms of action in rodent models of type 2 diabetes","volume":"150","author":"Szkudelska","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jnutbio.2017.04.014","article-title":"Effect of betaine on hepatic insulin resistance through FOXO1-induced NLRP3 inflammasome","volume":"45","author":"Kim","year":"2017","journal-title":"J. Nutr. Biochem."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"de Deus, I.J., Martins-Silva, A.F., Fagundes, M.M.A., Paula-Gomes, S., Silva, F.G.D.E., da Cruz, L.L., de Abreu, A.R.R., and de Queiroz, K.B. (2023). Role of NLRP3 inflammasome and oxidative stress in hepatic insulin resistance and the ameliorative effect of phytochemical intervention. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1188829"},{"key":"ref_120","first-page":"1","article-title":"Metabolic dysfunction-associated steatotic liver disease-induced changes in the antioxidant system: A review","volume":"99","year":"2025","journal-title":"Arch. Toxicol."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Liu, Y., Wang, Y., Zhou, J., Li, H., Liu, C., Zhong, B., Liu, J., Liu, L., Zhang, L., and Sun, L. (2025). Restoring metabolic flexibility: Targeting organelle interaction networks in the pathogenesis and therapy of MASLD. Front. Cell Dev. Biol., 13.","DOI":"10.3389\/fcell.2025.1718799"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"102634","DOI":"10.1016\/j.arr.2024.102634","article-title":"Betaine and aging: A narrative review of findings, possible mechanisms, research perspectives, and practical recommendations","volume":"104","author":"Zawieja","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"106022","DOI":"10.1016\/j.jff.2024.106022","article-title":"Protective effects of taurine and betaine against neurotoxicity via inhibition of endoplasmic reticulum stress and inflammation signaling in the brain of mice fed a Western diet","volume":"113","author":"Ko","year":"2024","journal-title":"J. Funct. Foods"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Saadati, S., Godini, R., Reddy, A., Teede, H., and Mousa, A. (2025). Metabolic crossroads in insulin resistance: Exploring lipid dysregulation and inflammation. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1692742"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Dua, A., Kumari, R., Singh, M., Kumar, R., Pradeep, S., Ojesina, A.I., and Kumar, R. (2025). Metabolic dysfunction-associated steatotic liver disease (MASLD): The interplay of gut microbiome, insulin resistance, and diabetes. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1618275"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"102218","DOI":"10.1016\/j.isci.2021.102218","article-title":"Dual regulation of TXNIP by ChREBP and FoxO1 in liver","volume":"24","author":"Noblet","year":"2021","journal-title":"iScience"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.4162\/nrp.2023.17.6.1084","article-title":"Maternal betaine supplementation ameliorates fatty liver disease in offspring mice by inhibiting hepatic NLRP3 inflammasome activation","volume":"17","author":"Li","year":"2023","journal-title":"Nutr. Res. Pract."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"9313436","DOI":"10.1155\/2022\/9313436","article-title":"Betaine inhibits NLRP3 inflammasome hyperactivation and regulates microglial M1\/M2 phenotypic differentiation, thereby attenuating lipopolysaccharide-induced depression-like behavior","volume":"2022","author":"Zhang","year":"2022","journal-title":"J. Immunol. Res."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Shi, H., Wang, X.L., Quan, H.F., Yan, L., Pei, X.Y., Wang, R., and Peng, X.D. (2019). Effects of betaine on LPS-stimulated activation of microglial M1\/M2 phenotypes by suppressing TLR4\/NF-\u03baB pathways in N9 cells. Molecules, 24.","DOI":"10.3390\/molecules24020367"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"300060521997590","DOI":"10.1177\/0300060521997590","article-title":"Role of TLR4\/MyD88\/NF-\u03baB signaling in heart and liver-related complications in a rat model of type 2 diabetes mellitus","volume":"49","author":"Tian","year":"2021","journal-title":"J. Int. Med. Res."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1007\/s10620-013-2775-x","article-title":"Betaine protects against high-fat-diet-induced liver injury by inhibition of high-mobility group box 1 and Toll-like receptor 4 expression in rats","volume":"58","author":"Zhang","year":"2013","journal-title":"Dig. Dis. Sci."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000535524","article-title":"Mechanisms and therapeutic strategies for MAFLD targeting TLR4 signaling pathways","volume":"16","author":"Ren","year":"2024","journal-title":"J. Innate Immun."},{"key":"ref_133","first-page":"1043","article-title":"Emerging roles of high-mobility group box-1 in liver disease","volume":"12","author":"Wang","year":"2024","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Contreras-Zentella, M.L., Hern\u00e1ndez-Espinosa, L.C., and Hern\u00e1ndez-Mu\u00f1oz, R. (2025). Oxidative stress in liver metabolic dysfunction and diseases, with a focus on hepatogenic diabetes: Effect of alcohol consumption. Antioxidants, 14.","DOI":"10.3390\/antiox14121494"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"C1637","DOI":"10.1152\/ajpcell.00951.2024","article-title":"Pathophysiological underpinnings of metabolic dysfunction-associated steatotic liver disease","volume":"328","author":"Kuchay","year":"2025","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Accacha, S., Barillas-Cerritos, J., Srivastava, A., Ross, F., Drewes, W., Gulkarov, S., De Leon, J., and Reiss, A.B. (2025). From childhood obesity to metabolic dysfunction-associated steatotic liver disease (MASLD) and hyperlipidemia through oxidative stress during childhood. Metabolites, 15.","DOI":"10.3390\/metabo15050287"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"e0639","DOI":"10.1097\/HC9.0000000000000639","article-title":"Adipokines regulate the development and progression of MASLD through organellar oxidative stress","volume":"9","author":"Zhao","year":"2025","journal-title":"Hepatol. Commun."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"474","DOI":"10.37349\/edd.2024.00062","article-title":"Mitochondrial ROS, a trigger for mitochondrial dysfunction and inflammasome activation and a therapeutic target in liver diseases","volume":"3","author":"Jaara","year":"2024","journal-title":"Explor. Dig. Dis."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00018-023-05061-7","article-title":"Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction","volume":"81","author":"LeFort","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"McCaffrey, J.M., and Ibdah, J.A. (2025). Effects of diet and exercise on mitochondrial health in metabolic dysfunction-associated steatotic liver disease (MASLD): Role of ceramides. Nutrients, 17.","DOI":"10.3390\/nu17182972"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"e180310","DOI":"10.1172\/JCI180310","article-title":"The senescence-associated secretome of Hedgehog-deficient hepatocytes drives MASLD progression","volume":"134","author":"Jun","year":"2024","journal-title":"J. Clin. Investig."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"e0365","DOI":"10.1097\/HC9.0000000000000365","article-title":"mARC1 in MASLD: Modulation of lipid accumulation in human hepatocytes and adipocytes","volume":"8","author":"Jones","year":"2024","journal-title":"Hepatol. Commun."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"7921","DOI":"10.1021\/acs.jafc.6b03592","article-title":"Antioxidant mechanism of betaine without free radical scavenging ability","volume":"64","author":"Zhang","year":"2016","journal-title":"J. Agric. Food Chem."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"101774","DOI":"10.1016\/j.aohep.2024.101774","article-title":"Mechanisms and therapeutic targets of mitochondria in the progression of metabolic dysfunction-associated steatotic liver disease","volume":"30","author":"Mu","year":"2025","journal-title":"Ann. Hepatol."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Li, X., Chen, W., Jia, Z., Xiao, Y., Shi, A., and Ma, X. (2025). Mitochondrial dysfunction as a pathogenesis and therapeutic strategy for metabolic dysfunction-associated steatotic liver disease. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26094256"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Caputo, V., Tarantino, G., Santini, S.J., Fracassi, G., and Balsano, C. (2023). The role of epigenetic control of mitochondrial (dys)function in MASLD onset and progression. Nutrients, 15.","DOI":"10.3390\/nu15224757"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm.2017.95","article-title":"AMPK: Guardian of metabolism and mitochondrial homeostasis","volume":"19","author":"Herzig","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Wang, H., Liu, X., Wang, C., Yu, S., Yang, X., Cao, X., Luo, M., Liu, S., and Zhang, C. (2025). Natural active botanical metabolites: Targeting AMPK signaling pathway to treat metabolic dysfunction-associated fatty liver disease. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1611400"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"100663","DOI":"10.1016\/j.crfs.2023.100663","article-title":"Role of autophagy in betaine-promoted hepatoprotection against non-alcoholic fatty liver disease in mice","volume":"8","author":"Seo","year":"2024","journal-title":"Curr. Res. Food Sci."},{"key":"ref_150","first-page":"425","article-title":"Research progress in the regulation of autophagy and mitochondrial homeostasis by AMPK signaling channels","volume":"36","author":"Ruan","year":"2024","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3945\/jn.108.094771","article-title":"Impaired sulfur-amino acid metabolism and oxidative stress in nonalcoholic fatty liver are alleviated by betaine supplementation in rats","volume":"139","author":"Kwon","year":"2009","journal-title":"J. Nutr."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Tapia, M., Tob\u00f3n-Cornejo, S., Noriega, L.G., V\u00e1zquez-Manjarrez, N., Couti\u00f1o-Hern\u00e1ndez, D., Granados-Portillo, O., Rom\u00e1n-Calleja, B.M., Ru\u00edz-Marg\u00e1in, A., Mac\u00edas-Rodr\u00edguez, R.U., and Tovar, A.R. (2024). Hepatic steatosis can be partly generated by the gut microbiota-mitochondria axis via 2-oleoyl glycerol and reversed by a combination of soy protein, chia oil, curcumin and nopal. Nutrients, 16.","DOI":"10.20944\/preprints202407.0745.v1"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"e186423","DOI":"10.1172\/JCI186423","article-title":"Metabolic dysfunction-associated steatotic liver disease and the gut microbiome: Pathogenic insights and therapeutic innovations","volume":"135","author":"Schnabl","year":"2025","journal-title":"J. Clin. Investig."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"e0484","DOI":"10.1097\/HC9.0000000000000484","article-title":"Gut microbial metabolites in MASLD: Implications of mitochondrial dysfunction in the pathogenesis and treatment","volume":"8","author":"Zhang","year":"2024","journal-title":"Hepatol. Commun."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"100096","DOI":"10.1016\/j.pharmr.2025.100096","article-title":"Endoplasmic reticulum stress at the forefront of fatty liver diseases and cancer","volume":"77","author":"Karin","year":"2025","journal-title":"Pharmacol. Rev."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nature07203","article-title":"From endoplasmic-reticulum stress to the inflammatory response","volume":"454","author":"Zhang","year":"2008","journal-title":"Nature"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/hep.32562","article-title":"Endoplasmic reticulum stress in liver diseases","volume":"77","author":"Ajoolabady","year":"2023","journal-title":"Hepatology"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/HEP.0000000000000786","article-title":"Molecular mechanisms in MASLD\/MASH-related HCC","volume":"82","author":"Wang","year":"2025","journal-title":"Hepatology"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/s42255-020-0261-2","article-title":"Fructose-stimulated de novo lipogenesis is promoted by inflammation","volume":"2","author":"Todoric","year":"2020","journal-title":"Nat. Metab."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12944-024-02108-x","article-title":"Updated mechanisms of MASLD pathogenesis","volume":"23","author":"Li","year":"2024","journal-title":"Lipids Health Dis."},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Kunja, C., Kumar, V., Kodam, P., Gopu, C.D., and Maity, S. (2025). ER stress sensors at the ER-mitochondrial interface, controlling mitochondrial health in neurodegenerative diseases. Front. Neurosci., 19.","DOI":"10.3389\/fnins.2025.1665272"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1002\/iid3.647","article-title":"The mitochondrial-associated endoplasmic reticulum membranes: A platform for the pathogenesis of inflammation-mediated metabolic diseases","volume":"10","author":"Degechisa","year":"2022","journal-title":"Immun. Inflamm. Dis."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12944-020-01210-0","article-title":"Mutual interaction between endoplasmic reticulum and mitochondria in nonalcoholic fatty liver disease","volume":"19","author":"Wang","year":"2020","journal-title":"Lipids Health Dis."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/hep.24396","article-title":"Activating transcription factor 6 plays protective and pathological roles in steatosis due to endoplasmic reticulum stress in zebrafish","volume":"54","author":"Cinaroglu","year":"2011","journal-title":"Hepatology"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"e186420","DOI":"10.1172\/JCI186420","article-title":"MASH: The nexus of metabolism, inflammation, and fibrosis","volume":"135","author":"Steinberg","year":"2025","journal-title":"J. Clin. Investig."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.jhep.2022.06.012","article-title":"Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease: Novel insights into cellular communication circuits","volume":"77","author":"Tacke","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s00011-026-02283-w","article-title":"From lipid overload to autophagy collapse: How lipid dysregulation drives chronic inflammation and metabolic disease","volume":"75","author":"Fomin","year":"2026","journal-title":"Inflamm. Res."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41575-025-01089-1","article-title":"Gut microbiome in metabolic dysfunction-associated steatotic liver disease and associated hepatocellular carcinoma","volume":"22","author":"Lau","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"479","DOI":"10.5009\/gnl240539","article-title":"Gut\u2013liver axis: The role of intestinal microbiota and their metabolites in the progression of metabolic dysfunction-associated steatotic liver disease","volume":"19","author":"Cui","year":"2025","journal-title":"Gut Liver"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: Pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","article-title":"The gut\u2013liver axis and gut microbiota in health and liver disease","volume":"21","author":"Hsu","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Bahitham, W., Banoun, Y., Aljahdali, M., Almuaiqly, G., Bahshwan, S.M., Aljahdali, L., Sanai, F.M., Rosado, A.S., and Sergi, C.M. (2025). \u201cTrust your gut\u201d: Exploring the connection between gut microbiome dysbiosis and the advancement of metabolic associated steatotic liver disease (MASLD)\/metabolic associated steatohepatitis (MASH): A systematic review of animal and human studies. Front. Nutr., 12.","DOI":"10.3389\/fnut.2025.1637071"},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Vallianou, N.G., Kounatidis, D., Psallida, S., Vythoulkas-Biotis, N., Adamou, A., Zachariadou, T., Kargioti, S., Karampela, I., and Dalamaga, M. (2024). NAFLD\/MASLD and the gut-liver axis: From pathogenesis to treatment options. Metabolites, 14.","DOI":"10.3390\/metabo14070366"},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Jin, M., Shen, Y., Pan, T., Zhu, T., Li, X., Xu, F., Betancor, M.B., Jiao, L., Tocher, D.R., and Zhou, Q. (2021). Dietary betaine mitigates hepatic steatosis and inflammation induced by a high-fat diet by modulating the Sirt1\/SREBP-1\/PPAR\u03b1 pathway in juvenile black seabream (Acanthopagrus schlegelii). Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.694720"},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Wu, J., He, C., Bu, J., Luo, Y., Yang, S., Ye, C., Yu, S., He, B., Yin, Y., and Yang, X. (2020). Betaine attenuates LPS-induced downregulation of occludin and claudin-1 and restores intestinal barrier function. BMC Vet. Res., 16.","DOI":"10.1186\/s12917-020-02298-3"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"21850","DOI":"10.1038\/s41598-020-78935-6","article-title":"Betaine inhibits Toll-like receptor 4 responses and restores intestinal microbiota in acute liver failure mice","volume":"10","author":"Chen","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Ferenc, K., Sokal-Dembowska, A., Helma, K., Motyka, E., Jarmakiewicz-Czaja, S., and Filip, R. (2024). Modulation of the gut microbiota by nutrition and its relationship to epigenetics. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25021228"},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Li, S., Xu, S., Zhao, Y., Wang, H., and Feng, J. (2020). Dietary betaine addition promotes hepatic cholesterol synthesis, bile acid conversion, and export in rats. Nutrients, 12.","DOI":"10.3390\/nu12051399"},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Milosevic, I., Vujovic, A., Barac, A., Djelic, M., Korac, M., Radovanovic Spurnic, A., Gmizic, I., Stevanovic, O., Djordjevic, V., and Russo, E. (2019). Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: A review of the literature. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20020395"},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Wang, L., Cao, Z.M., Zhang, L.L., Li, J.M., and Lv, W.L. (2022). The role of gut microbiota in some liver diseases: From an immunological perspective. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.923599"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"12814","DOI":"10.1039\/D2FO02942A","article-title":"Betaine supplementation alleviates dextran sulfate sodium-induced colitis via regulating the inflammatory response, enhancing the intestinal barrier, and altering gut microbiota","volume":"13","author":"Zhao","year":"2022","journal-title":"Food Funct."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40104-024-00998-6","article-title":"Betaine addition to the diet alleviates intestinal injury in growing rabbits during the summer heat through the AAT\/mTOR pathway","volume":"15","author":"Li","year":"2024","journal-title":"J. Anim. Sci. Biotechnol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","article-title":"Altered profile of human gut microbiome is associated with cirrhosis and its complications","volume":"60","author":"Bajaj","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4291\/wjgp.v6.i4.110","article-title":"New-found link between microbiota and obesity","volume":"6","author":"Chakraborti","year":"2015","journal-title":"World J. Gastrointest. Pathophysiol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1862612","DOI":"10.1080\/19490976.2020.1862612","article-title":"Dietary betaine prevents obesity through gut microbiota-driven microRNA-378a family","volume":"13","author":"Du","year":"2021","journal-title":"Gut Microbes"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.intimp.2016.07.028","article-title":"High-fat diet plus carbon tetrachloride-induced liver fibrosis is alleviated by betaine treatment in rats","volume":"39","author":"Uysal","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4103\/sjg.SJG_297_17","article-title":"Involvement of epithelial-mesenchymal transition in liver fibrosis","volume":"24","author":"Yu","year":"2018","journal-title":"Saudi J. Gastroenterol."},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Di Gregorio, J., Robuffo, I., Spalletta, S., Giambuzzi, G., De Iuliis, V., Toniato, E., Martinotti, S., Conti, P., and Flati, V. (2020). The epithelial-to-mesenchymal transition as a possible therapeutic target in fibrotic disorders. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.607483"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/hep.23239","article-title":"Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo-controlled trial","volume":"50","author":"Abdelmalek","year":"2009","journal-title":"Hepatology"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1097\/HEP.0000000000001477","article-title":"Pilot trials of oral betaine in participants with metabolic dysfunction-associated steatotic liver disease and elevated alanine aminotransferase","volume":"83","author":"Lim","year":"2026","journal-title":"Hepatology"}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/15\/9\/1209\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:33:09Z","timestamp":1789983189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/15\/9\/1209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,20]]},"references-count":190,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["antiox15091209"],"URL":"https:\/\/doi.org\/10.3390\/antiox15091209","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,20]]}}}